Related by context. All words. (Click for frequent words.) 68 Phase Ib II 67 Recordati SpA 67 MolMed 67 Novuspharma 66 Menarini 66 Noscira 66 Creabilis Therapeutics 65 Cosmo Pharmaceuticals 65 WILEX 65 phase IIb trial 65 Newron Pharmaceuticals SpA 64 HGS# 64 Fresenius Biotech 64 Menarini Group 64 Vernalis plc 64 Nasdaq PGNX today 64 ADVANCE PD 64 multicenter Phase II 64 Biopartners 64 faropenem 64 YONDELIS R 64 phase IIa clinical 64 Newron Pharmaceuticals 64 bilastine 64 FOLOTYN ® 64 Sirion Therapeutics 64 CONBRIZA 64 Kiadis Pharma 63 Guerbet 63 Nexavar sorafenib 63 Canvaxin 63 Auxilium Pharma 63 Pharmion Corporation 63 oral antiviral 63 Pierre Fabre Medicament 63 AB OMXS BINV 63 Grunenthal GmbH 63 BioNumerik 63 Rapinyl 63 Tibotec BVBA 63 Kosan dependence 63 PHX# 63 phase IIb 63 YONDELIS 63 Napo Pharmaceuticals 63 Kiadis 63 Loramyc 63 Igeneon 63 Medidur FA 63 Sigma Tau 62 Fovea Pharmaceuticals 62 Proellex TM 62 ViroStatics 62 Dynogen 62 SpePharm 62 Théramex 62 Synosia Therapeutics 62 Sigma Tau Pharmaceuticals 62 inVentiv Clinical 62 ospemifene 62 ularitide 62 phase IIa 62 PharmaMar 62 Merck Serono division 62 placebo controlled Phase III 62 Intendis 62 Aplidin 62 Biolipox 62 PregLem 62 sigma tau Group 62 Addex Pharmaceuticals 62 Wellstat 62 Prometheus Laboratories 62 trastuzumab DM1 T DM1 62 Adenuric R 62 Lung Rx 62 UCB SA 62 Oncoscience 62 Agennix Incorporated 62 FlutiformTM 62 Removab 62 copromotion 62 Myocet 62 Debiopharm SA 62 Helsinn 61 Kuvan R 61 Cerep 61 SOBI 61 Phase IIIb clinical 61 alvespimycin 61 Zentaris 61 neratinib 61 Loramyc R 61 Phase IIb clinical trials 61 Almirall SA 61 phase Ib 61 oral salmon calcitonin 61 Nycomed GmbH 61 ESBATech AG 61 Spirogen 61 NASDAQ NABI 61 Galderma SA 61 phase IIb clinical 61 Proteo 61 DPX Survivac 61 pradefovir 61 Gastrotech 61 TheraCIM 61 Merck KGaA Darmstadt Germany 61 PF # [002] 61 NerPharMa 61 ALTANA Pharma AG 61 Cutanea 61 initiate Phase IIb 61 Portola Pharmaceuticals 61 Roche SWX ROG 61 Zenyaku Kogyo 61 Aryplase 61 Basilea Pharmaceutica AG 61 Theramex 61 Phase #b/#a 61 mertansine 61 LibiGel ® 61 EnzymeRx 61 Idera Pharmaceuticals 61 PDE4 inhibitor 61 Sanochemia Pharmazeutika AG 61 immatics 61 NASDAQ PHRM 61 Phase IIb III 61 BRIM3 61 PsychoGenics 61 NASDAQ ABII 61 entinostat 61 Phase #/#a 61 Æterna Zentaris 61 Antisoma plc 61 Astex Therapeutics 61 Vaccinex 61 Phase 1b trial 61 TFChem 61 SUTENT ® 61 IL# PE#QQR 61 Erbitux cetuximab 61 JAK inhibitor 61 atacicept 61 Arpida Ltd. 61 SANOFI AVENTIS 61 PDE# inhibitors 61 THALOMID 60 Lovaza TM 60 Neulasta R 60 Norgine BV 60 Chiesi Farmaceutici 60 oral ridaforolimus 60 TiGenix 60 elotuzumab 60 SinuNase ™ 60 Phase Ib study 60 romidepsin 60 midstage clinical 60 eprotirome 60 Tibotec Pharmaceuticals Ltd. 60 commercialize OncoGenex lead 60 Alnara Pharmaceuticals 60 Campath ® 60 Antisense Pharma 60 Cabrellis 60 rALLy clinical trial 60 phase IIIb 60 LFB Biotechnologies 60 Ergomed 60 Amrubicin 60 Sanochemia 60 Nitec Pharma 60 Helsinn Healthcare 60 WILEX AG 60 CDP# 60 Civacir 60 Orphan Therapeutics 60 Vimpat lacosamide 60 UCB Pharma SA 60 sigma tau 60 Cloretazine ® 60 Marketing Authorisation Application 60 Cascade LifeSciences 60 Nuon Therapeutics 60 Alligator Bioscience AB 60 forodesine 60 Vimpat ® lacosamide 60 Afatinib 60 fostamatinib 60 Gruppo Angelini 60 Fournier Pharma 60 Curacyte AG 60 SciClone Pharmaceuticals Inc. 60 Merz Pharmaceuticals GmbH 60 Cerimon 60 Evoltra 60 Phase 2b clinical 60 AEG# 60 budesonide MMX Phase III 60 Cetrorelix 60 Meritage Pharma 60 Shigamabs ® 60 ProFibrix 60 QuatRx 60 Helsinn Healthcare SA 60 Yondelis ® 60 Evotec AG 60 Allovectin 7 ® 60 Initiates Enrollment 60 Cutanea Life Sciences 60 Jean Pierre Sommadossi Ph.D. 60 frovatriptan 60 Cx# [002] 60 Galenea 60 NASDAQ FLML 60 Stock Exchange EVT TecDAX 60 JOULFERON 60 Syndax 60 Uvidem 60 Euroscreen 60 MAGE A3 ASCI 60 CoTherix 60 Zenvia ™ 60 Phase IIIB IV 60 ruxolitinib 60 glucokinase activator 60 adrenergic regulation 60 Tykerb lapatinib 60 Davanat 60 MabThera rituximab 60 Arno Therapeutics 60 HELSINN 60 Pharmexa Epimmune 59 ExonHit Therapeutics SA 59 NASDAQ CLSN 59 Manja Bouman CEO 59 Nerviano Medical Sciences 59 Plicera 59 Sanofi aventis EURONEXT SAN 59 Nippon Shinyaku 59 Ibis Biosciences 59 Galapagos NV 59 Innogenetics NV 59 Gendux 59 Germany FSE SCH 59 Ipsen Euronext IPN 59 Endotis Pharma 59 Veregen R 59 Phase IIIb study 59 LAS# [002] 59 SYCREST 59 Esteve SA 59 Fludara ® 59 thetreatment 59 Genentech Roche 59 Prism Pharmaceuticals 59 Sanvar R 59 Proquin XR 59 Lixivaptan 59 Abbott Molecular 59 Phase Ib clinical 59 TOPICA 59 CVac 59 PRT# 59 tramiprosate Alzhemed TM 59 Febuxostat 59 Prosensa 59 Vion Pharmaceuticals 59 Biovitrum AB 59 rThrombin 59 Novolimus 59 Rottapharm Madaus 59 enzastaurin 59 Gedeon Richter Plc 59 PrevOnco 59 Neuropharma 59 Nitec 59 aflibercept 59 NYSE SHR 59 deforolimus 59 SAR# [004] 59 Oasmia 59 Chiesi Farmaceutici SpA 59 Fujisawa Healthcare Inc. 59 Sankyo Pharma 59 Gendux AB 59 Taiho Pharmaceutical 59 Phase 2a trial 59 Ore Pharmaceuticals 59 CRMD# 59 Siena Biotech 59 ZEFTERA TM Zevtera TM 59 silodosin 59 AVAX 59 sunitinib malate 59 Allovectin 7 59 Dr. Gabriel Lasala 59 BioTie 59 AngioChem 59 REMEDIAL II 59 pain palliation 59 DeveloGen 59 NVA# 59 ThermoDox R 59 Alvesco R 59 Junovan TM 59 PRECISE trial 59 Clinquest 59 Loramyc ™ 59 Innovive Pharmaceuticals 59 Multiferon ® 59 methylnaltrexone bromide 59 Ambrilia Biopharma 59 balsalazide tablet 59 HaptoGuard 59 Akela Pharma 59 Minapharm 59 Aegerion 59 Roche OTC RHHBY 59 midstage trials 59 Veridex LLC 59 OMP designation 59 Eribulin 59 Tragara Pharmaceuticals Inc. 59 Berlex Biosciences 59 Intarcia 59 Addrenex 59 OvaRex 59 Agile Therapeutics 59 severe hypercholesterolemia 59 Addrenex Pharmaceuticals 59 Dexo 59 phase IIb study 59 Rebif ® 59 Phase IIa trial 59 Pierre Fabre SA 59 Stragen 59 confirmatory clinical 59 SkyePharma PLC 59 apaziquone 59 Panzem R NCD 59 TRB Chemedica 59 Bayer HealthCare AG 59 Adentri 59 SciClone Pharmaceuticals 59 Raptiva R 59 ongoing Phase 1b 59 Phase Ib 59 Vifor Pharma 59 AVN# Phase 59 Clavis Pharma 59 Marketing Authorisation Application MAA 59 Preotact R 59 RHEI Pharmaceuticals 59 GTC NASDAQ GTCB 59 terlipressin 59 mondoBIOTECH 59 ELACYT 59 Sanvar 59 Melior Discovery 59 dose escalation clinical 59 Biomedica 59 Alseres 59 Modrenal R 59 gepirone ER 59 CureTech 59 Solazed 58 Gedeon Richter 58 Martin Nicklasson 58 OncoGel 58 Falk Pharma 58 Celladon Corporation 58 ocrelizumab 58 KuDOS 58 CA9 SCAN 58 Nasdaq ONXX today 58 lixivaptan 58 Ipsen SA 58 SNT MC# 58 OncoMethylome Sciences 58 Zeneus 58 Targretin 58 Gattex 58 Dacogen injection 58 Actelion Ltd 58 oral prodrug 58 Gentamicin Surgical Implant 58 Aurexis 58 mitogen activated ERK kinase 58 Swedish Orphan Biovitrum 58 Affimed Therapeutics AG 58 Wilex AG 58 RGB # 58 ALN RSV program 58 elbion 58 sanofi 58 Velcade bortezomib 58 ELIQUIS 58 CAPHOSOL R 58 Biotec Pharmacon 58 Neuro3d 58 Nasdaq CGEN 58 Enzo Therapeutics 58 lexidronam injection 58 histamine dihydrochloride 58 Xyrem ® 58 SCHWARZ PHARMA 58 PSN# [001] 58 ProSkelia 58 Antisense Pharma GmbH 58 Phase 2b study 58 Speedel Holding AG 58 Hedgehog antagonist 58 Paris IPN 58 Trofex 58 axitinib 58 Insegia 58 Proxinium TM 58 markets HP Acthar 58 Nasdaq ENZN 58 Portola Pharmaceuticals Inc. 58 Georges Gemayel 58 fidaxomicin Phase 3 58 ProSavin 58 HuMax CD4 58 Oglemilast 58 Santhera 58 inVentiv Clinical Solutions 58 Bio3 Research 58 Cloretazine 58 OncoVex 58 Acapodene 58 Vascular Wrap TM 58 Diatos 58 Integromics 58 Somatuline R Autogel R 58 RPL# 58 Selvita 58 supplemental biologics 58 Tracleer r 58 Exploit collaboration 58 CR# vcMMAE 58 GLPG# 58 Tocosol Paclitaxel 58 Zybrestat 58 Oceana Therapeutics 58 zanolimumab 58 Urocidin 58 PhotoCure 58 Photocure 58 TOCOSOL Paclitaxel 58 Caleco Pharma 58 Tracleer R 58 IV APAP 58 Anthony Giovinazzo 58 Adventrx 58 Elafin 58 EP #R 58 Axxam 58 AAIPharma 58 AdnaGen AG 58 ARIXTRA R 58 trastuzumab DM1 58 HuLuc# 58 Merz Pharmaceuticals 58 Polyphor 58 KYTHERA 58 NASDAQ NYMX 58 bardoxolone 58 clevidipine 58 Esmya 58 Lodotra 58 Innate Pharma 58 NASDAQ PGNX 58 Medigene 58 Polymeropoulos 58 fipamezole 58 Tarceva TM 58 ATL# [001] 58 H3 Pharma 58 Paion AG 58 Surfaxin LS 58 Agios Pharmaceuticals 58 incyclinide 58 Vernakalant 58 MERLIN TIMI 58 antibacterial therapeutics 58 MOVIPREP R 58 Ziopharm 58 Argenta Discovery 58 compound KOS 58 Synt em 58 Inspiration Biopharmaceuticals 58 Ascenta Therapeutics 58 Reverset 58 TRACON Pharmaceuticals 58 amrubicin 58 apricitabine 58 Rezular 58 registrational studies 58 lomitapide 58 Phenomix Corporation 58 pivotal bioequivalence 58 Dr. Halvor Jaeger 58 Medicsight PLC 58 Fumapharm 58 ThromboGenics NV 58 Isotechnika Pharma 58 Nasdaq INHX 58 Nexavar ® 58 multicenter randomized Phase III 58 Azur Pharma 58 Euronext SAN 58 Elocalcitol 58 Keppra ® levetiracetam 58 Nanobody R 58 Progenics Pharmaceuticals 58 CyDex Pharmaceuticals 58 MicroDose 58 Cellegesic 58 BioXell 58 OMNARIS Nasal Spray 58 Solstice Neurosciences 58 Michele Garufi Chairman 58 APEX PD 58 Apitope 58 Vitaxin 58 Prestara 58 Zevtera TM 58 Taxotere docetaxel 58 sanofi aventis SNY 58 Phase Ib IIa 58 Gemin X Biotechnologies 58 IMiDs ® compound 58 Sebivo 58 Oncodesign 58 Lantibio 58 Personalized Immunotherapy 58 Axentis Pharma 58 IV Busulfex 58 Annamycin 58 methylnaltrexone 58 alvimopan 58 OvaRex R 58 ORENCIA R 58 Fortigel 58 TBC# 58 Alvesco ® 58 teriflunomide 58 SUCCEED trial 58 Evotec OAI 58 Phase 2b kidney transplant 58 JV SpeBio 58 Phoqus 57 Pazopanib 57 Stallergenes SA 57 voclosporin 57 reslizumab 57 hoFH 57 omacetaxine 57 CRLX# 57 StemEx R 57 Begins Dosing 57 Entereg R 57 AERx iDMS 57 Pervasis 57 FluoroPharma 57 SWX RO SWX ROG 57 EpiTherapeutics 57 Opsona Therapeutics 57 CIMZIA r 57 Mepact 57 Teikoku Pharma USA 57 clinical pharmacology studies 57 Phenomix 57 Cenix BioScience 57 Tripep 57 Aerovance 57 Tigris Pharmaceuticals 57 Lupuzor 57 INCB# [001] 57 Bracco Diagnostics Inc. 57 Paion 57 Potelligent Technology 57 Orexo AB 57 HepeX B 57 OvaRex ® MAb 57 ZURICH AFX Novartis AG 57 NovImmune 57 ocular formulation 57 bicifadine 57 aerosolized AAT 57 GlaxoSmithKline plc GSK 57 Genasense ® 57 Echelon Biosciences 57 Initiates Clinical Trial 57 Akesis 57 PAION AG 57 bazedoxifene 57 ENZON 57 DRAXIMAGE 57 Idenix Pharma 57 Phenoptin 57 Oscient Pharmaceuticals 57 dutogliptin 57 BLP# Liposome Vaccine 57 L BLP# 57 huC# DM4 57 Tranzyme Pharma 57 Velac 57 Mipomersen 57 SALVAT 57 NV Organon 57 Affimed 57 SkyePharma Plc 57 RSD# oral 57 Phase 2a 57 Ipsen Euronext FR# 57 Tostrex 57 Numoda 57 opioid induced bowel dysfunction 57 SpeBio 57 Theratope 57 ViaCyte 57 Digna Biotech 57 Panzem 57 Regeneron Pharma 57 STO SOBI 57 Vernalis Plc 57 pafuramidine maleate 57 ENDEAVOR IV 57 IMA# 57 Akela Pharma Inc. 57 Altana Pharma 57 tremelimumab 57 CancerVax Corporation 57 Phase IIa 57 Recordati 57 Fondazione Telethon 57 Angioblast 57 Stimuvax R 57 Combidex 57 FoldRx 57 SR Pharma 57 Adamis Pharmaceuticals 57 Fibrin Pad 57 IPSEN 57 Kyowa Hakko Kirin 57 candidate CRLX# 57 Asentar 57 ganaxolone 57 Fodosine 57 Doliveux 57 PDL# 57 FoldRx Pharmaceuticals Inc. 57 Avidex 57 Immunotherapeutic 57 NYSE BMY PR 57 SciClone Pharma 57 ongoing Phase IIIb 57 Trophos 57 Perforomist ™ Inhalation Solution 57 AnGes MG Inc. 57 Tyzeka Sebivo 57 Cardiokine 57 dalbavancin 57 Albugon 57 Adenuric ® 57 IGXT IntelGenx today 57 antisense inhibitors 57 THR beta agonist 57 BioAlliance Pharma 57 RIGScan CR 57 EXPLORE Xa 57 GEM OS2 57 tiapamil 57 Zadaxin 57 DiaPep# 57 DAIICHI SANKYO 57 Enobia 57 randomized Phase 2b 57 Mycamine 57 Epiphany Biosciences 57 Hesperion 57 Dacogen TM 57 Xanodyne 57 Azedra 57 Flutiform TM 57 Loramyc ® 57 Xcytrin R 57 VentiRx 57 pharmacokinetic PK study 57 inhaled AAT 57 ERYtech Pharma 57 Mycograb 57 Astellas Deutschland GmbH 57 Regulus Therapeutics 57 Bicifadine 57 Nordic Bioscience 57 SOLVAY PHARMACEUTICALS 57 Salmedix 57 Cethrin 57 confirmatory Phase III 57 Multiferon 57 Ercole Biotech 57 BioInvent 57 Kulmbach Germany 57 GeneraMedix Inc. 57 leading oral taxane 57 Hybridon 57 cardio renal 57 ICON7 57 Agenus 57 Adamed 57 initiate Phase 1b 57 Transave 57 Astex Therapeutics Limited 57 Active Biotech AB 57 Glassia 57 ATG Fresenius S 57 Lupin Pharmaceuticals 57 novel oral anticoagulant 57 NeuroSolutions 57 Phase 1a clinical 57 PROSTVAC ® 57 AC Immune 57 EOquin TM 57 Evoltra TM 57 lorvotuzumab mertansine 57 Ixempra 57 ImmuPharma 57 Cabrellis Pharmaceuticals 57 NeuroMedix 57 Gemin X 57 CINOD 57 Celmed 57 PREOS R 57 Pronova 57 IMiDs R 57 registrational 57 EndoTAG TM 57 Adenosine Therapeutics 57 XL# XL# XL# XL# 57 TKPHF 57 intravenous acetaminophen 57 Meda STO MEDAA 57 commercialize AzaSite 57 OGeS 57 Regado Biosciences 57 Evoltra ® 57 Vascular Wrap 57 Veronate 57 Reports Preclinical Data 57 REMUNE R 57 CeNeS Pharmaceuticals plc 57 Pyridorin 57 Calixa 57 Phase IIb trials 57 RAPTIVA r 57 Solasia 57 RESOLOR 57 Phase III randomized controlled 57 LONDON AFX GlaxoSmithKline PLC 57 Symphogen 57 Scynexis 57 safinamide 57 Neurimmune 57 Xybion 57 Panzem R 57 Gentium 57 Paladin Labs 57 Pronova BioPharma 57 Fabre Kramer 57 Summary Genmab 57 diabetic neuropathic pain 57 Ramoplanin 57 Silodosin 57 CIP ISOTRETINOIN 57 Cenomed 57 UPLYSO 57 oral picoplatin 57 Flamel Technologies 57 lintuzumab SGN 57 Alfa Wassermann SpA 57 Grunenthal 57 epigenetic therapies 57 Affitech AS 57 Orphan Drug status 57 Phase III psoriasis 57 Alnylam Pharma 57 Ophthotech 57 Nasdaq OSCI 57 TransMolecular 57 RECOTHROM ® 57 Phase 2b trial 57 Calistoga Pharmaceuticals 57 brivaracetam 56 Cancidas 56 Esprit Pharma 56 PEARL SC 56 iniparib 56 RECOTHROM R 56 Alinia 56 Nasdaq ABII 56 fosbretabulin 56 FACTIVE R gemifloxacin 56 GRN# 56 Somatuline Depot 56 Kissei Pharmaceutical 56 EGS# 56 Prima BioMed 56 Graffinity Pharmaceuticals 56 Gelclair 56 PLAVIX ® 56 Ilaris ® 56 betrixaban 56 Plenaxis R 56 Bracco Imaging 56 Apricus Bio 56 talactoferrin 56 Aegera Therapeutics 56 oxymorphone ER 56 Friedreich Ataxia FRDA 56 LibiGel Phase III 56 BrachySil TM 56 Endotis 56 Roland Haefeli 56 HuMax EGFr 56 Transgene SA 56 ProBioGen 56 Peginterferon alfa 2b 56 NKT Therapeutics 56 Onco TCS 56 Therinject 56 H. Willard Flamel 56 TESARO 56 Nautilus Biotech 56 volociximab 56 AZX# 56 Onalta 56 Novexel 56 Zenvia Phase III 56 Phase 2b clinical trials 56 Memryte 56 Lumacan 56 Orapred ODT 56 tranilast 56 PPD Nasdaq PPDI 56 CURE AF 56 Quark Biotech Inc. 56 eniluracil 56 Veregen 56 Trubion Pharma 56 BTG plc 56 Shanghai Medicilon 56 Clinuvel 56 Lexiscan ® 56 ZYBRESTAT fosbretabulin 56 Phase III clinical 56 dihydrochloride Tablets 56 #D#C# 56 Emisphere Technologies 56 Novartis NVS Snapshot Report 56 afamelanotide 56 ASA# 56 Increlex R 56 Metabolex 56 STEDESA 56 novel therapeutic antibodies 56 AQ4N 56 Multiferon R 56 Archemix Corp. 56 InNexus Biotechnology 56 Juvantia 56 Phase 2a clinical 56 Therabel 56 Tolerx 56 therapeutic monoclonal antibody 56 Zavesca r 56 JP-#/fipamezole 56 MolecularMD 56 rALLy trial 56 Alliant Pharmaceuticals 56 VivaGel ™ 56 Apexigen 56 vosaroxin 56 Rezonic 56 MacroChem 56 t2cure GmbH 56 NewBridge Pharmaceuticals 56 Frank Condella 56 isavuconazole 56 PharmaSwiss 56 ImQuest 56 ZOLINZA 56 HuMax TAC 56 Vicuron Pharmaceuticals 56 Onyx Pharmaceuticals Inc 56 Phynova 56 RenalGuard System TM 56 Aeterna Zentaris 56 NASDAQ ALNY 56 Janssen Pharmaceutica NV 56 danoprevir 56 Ophena 56 LIVALO 56 Cellerix 56 Vaccinogen 56 randomized Phase IIb 56 Medivir STO MVIRB 56 vinflunine 56 Abstral 56 randomized controlled multicenter 56 Desmoteplase 56 bevirimat Study 56 Val HeFT 56 EndoTAG 56 investigational HCV polymerase 56 Organon Pharmaceuticals 56 Dynepo TM 56 Amira Pharmaceuticals 56 Eckard Weber 56 riociguat 56 phase 2a 56 Karo Bio 56 INTERCEPT platelets 56 Schweizerhall 56 kidney urologic 56 AEterna 56 ImaginAb 56 TELINTRA 56 successfully commercialize Iluvien 56 sanofi aventis EURONEXT SAN 56 Voraxaze ™ 56 Phase IIb trial 56 BioAxone 56 Transcept Pharmaceuticals 56 Trofex TM 56 CCR9 antagonist 56 RhuDex 56 Nanobiotix 56 Luteinizing Hormone Releasing Hormone 56 Voraxaze 56 NP2 Enkephalin 56 TOCOSOL Camptothecin 56 ProLindac TM 56 Aviptadil 56 Excaliard 56 OncoGenex Technologies 56 Presents Preclinical 56 Grünenthal GmbH 56 Celator 56 Les Laboratoires Servier 56 dexanabinol 56 trastuzumab emtansine T DM1 56 Merz Pharma Group 56 EOquin 56 Ketotransdel 56 DNA methylation biomarkers 56 Cimzia ® certolizumab pegol 56 mSEPT9 biomarker 56 telomerase therapeutic 56 CHAMPION PCI 56 tubulin inhibitor 56 ticagrelor Brilinta 56 RAPTIVA R 56 Posidur 56 double blinded randomized 56 Phase IIa clinical 56 Phase III TRIST 56 midstage clinical trials 56 Somatuline Autogel 56 Axiogenesis 56 Agendia BV 56 Simdax 56 Paris IPN Euronext 56 daptomycin 56 Zalbin 56 herpetic keratitis 56 Agennix 56 CytoFabTM 56 LEUKINE 56 oral taxane 56 Phase 1b clinical 56 Onyx Pharma 56 Joulferon 56 anidulafungin 56 SYGNIS 56 Novartis AG NOVN.VX 56 thalidomide Thalomid 56 preclinical pharmacology 56 Egrifta 56 Institut Jules Bordet 56 Valdoxan 56 Idun Pharmaceuticals 56 Clonicel